| Application no. and date | 11002906.3 (espacenet) (Federated) (European Patent Register), 20060606 | | Patent/reg. no. and date | DK/EP 2390267, 20130605 | | Publication date | 20111130 | | Priority no. and date | US 687971 P, 20050607, US 785353 P, 20060323 | | EP pub. no. and date |
EP 2390267 20111130 | | Effective date | | | Applicant/owner | ESBATech - a Novartis Company LLC, Wagistrasse 21
8952 Schlieren, CH | | Applicant ref. no. | P81303514DK00E | | Inventor | URECH, David, Widmen 8
8634 Hombrechtikon, CH,
Ewert, Stefan, Baselmattweg 116
4123 Allschwil, CH,
Auf der Maur, Adrian, Badenerstrasse 19A
8953 Dietikon, CH,
Barberis, Alcide, Solario
6718 Olivone, CH,
Lichtlen, Peter, Obstgartenstrasse 16
8136 Gattikon, CH | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 29/00 (2006.01) , A61P 37/00 (2006.01) , C07K 16/24 (2006.01) , C12N 15/13 (2006.01) , G01N 33/53 (2006.01) | | Title | Stabile og opløselige antistoffer, der hæmmer TNF(alfa) | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
